Primary Appointment

After earning his bachelor's degree in biochemistry with honors from the University of California, Berkeley, and his Medical degree from the University of California, Davis, Dr. Yeh trained as an immunologist under Nobel laureate Dr. Baruj Benacerraf at Harvard Medical School, Boston. In 1987, he was appointed Assistant Professor of Medicine at the Massachusetts General Hospital and Harvard Medical School. He is board-certified in Internal Medicine, Cardiovascular Diseases, and Nuclear Cardiology. In 1992, Dr. Yeh joined the faculty of The University of Texas Health Science Center at Houston. His laboratory has discovered three novel biochemical pathways (SUMOylation, Neddylation, and GPI anchor biosynthesis) that have revolutionized our understanding of cell cycle progression, cell signaling, and the pathogenesis of leukemia. His laboratory is also at the forefront in deciphering the role of inflammation in the development of atherosclerosis and in the study of using stem cells to repair damaged heart muscles. He has received grants from the National Institute of Health and support from the Massachusetts General Hospital/Upjohn Scholarship, Arthritis Investigator Award from the Arthritis Foundation, and the Established Investigator Award from the American Heart Association. Dr. Yeh has mentored a large number of physician/scientists and basic scientists, who have become independent investigators. He has written over 100 scientific papers, many of which are landmark contributions to science and medicine. He is the founding Chairman of the Department of Cardiology at the University of Texas M. D. Anderson Cancer Center. Among his many honors, Dr. Yeh was elected to memberships in Academia Sinica, the Association of American Physicians, and the American Society for Clinical Investigation. He was selected as the Distinguished Alumnus of the University of California, Davis Medical School and has served for ten years as Associate Editor of Circulation. Dr. Yeh is a member of the Texas Heart Institute and currently serves as a board member of the American Heart Association, Southwestern Affiliate. He has held prominent positions as the President of the Houston Cardiology Society and President of the board of American Heart Association, Houston Chapter.

SUMOylation

NEDDylation

Stem cell transplant for congestive heart failure

Cardiac complications of anti-cancer therapy

The role of inflammation in the development of coronary artery disease

Congestive Heart Failure

Last updated: 11/19/2009